https://idwiki.org/index.php?action=history&feed=atom&title=Golimumab 2026-04-28T19:24:43Z Revision history for this page on the wiki MediaWiki 1.43.8 https://idwiki.org/index.php?title=Golimumab&diff=11281&oldid=prev 2025-09-29T18:37:38Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 18:37, 29 September 2025</td> </tr><tr> <td colspan="2" class="diff-lineno">Line 1:</td> <td colspan="2" class="diff-lineno">Line 1:</td> </tr> <tr> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Humanized monoclonal antibody targeting TNF</div></td> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Humanized monoclonal antibody targeting TNF</div></td> </tr> <tr> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Indications including [[rheumatoid arthritis]], [[psoriatic arthritis]], and [[ankylosing spondylitis]]</div></td> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Indications including [[rheumatoid arthritis]], [[psoriatic arthritis]], and [[ankylosing spondylitis]]</div></td> </tr> <tr> <td colspan="2" class="diff-empty diff-side-deleted"></td> <td class="diff-marker" data-marker="+"></td> <td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* Adverse effects include URTI, sinusitis, bronchitis, viral infections (including hepatitis B reactivation), superficial fungal infections, invasive fungal infections, tuberculosis</div></td> </tr> <tr> <td colspan="2" class="diff-empty diff-side-deleted"></td> <td class="diff-marker" data-marker="+"></td> <td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>** Also elevated ALT, local injection site reactions, hypertension, dizziness, paresthesia, constipation</div></td> </tr> <tr> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br /></td> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br /></td> </tr> <tr> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Monoclonal antibodies]]</div></td> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Monoclonal antibodies]]</div></td> </tr> <!-- diff cache key site7_mediawiki:diff:1.41:old-11280:rev-11281:wikidiff2=table:1.13.0:bc2a06be --> </table>

Aidan https://idwiki.org/index.php?title=Golimumab&diff=11280&oldid=prev 2025-09-29T18:35:24Z

<p>Created page with &quot;* Humanized monoclonal antibody targeting TNF * Indications including <a href="/Rheumatoid_arthritis" title="Rheumatoid arthritis">rheumatoid arthritis</a>, <a href="/index.php?title=Psoriatic_arthritis&amp;action=edit&amp;redlink=1" class="new" title="Psoriatic arthritis (page does not exist)">psoriatic arthritis</a>, and <a href="/Ankylosing_spondylitis" title="Ankylosing spondylitis">ankylosing spondylitis</a> <a href="/Category:Monoclonal_antibodies" title="Category:Monoclonal antibodies">Category:Monoclonal antibodies</a>&quot;</p> <p><b>New page</b></p><div>* Humanized monoclonal antibody targeting TNF<br /> * Indications including [[rheumatoid arthritis]], [[psoriatic arthritis]], and [[ankylosing spondylitis]]<br /> <br /> [[Category:Monoclonal antibodies]]</div>

Aidan